Quick Heal Tech

₹457.6 -1.6 | 0.3%

WEBSITE BSE:539678 NSE : QUICKHEAL 10 May, 16:01

Market Cap ₹2449 Cr.

Stock P/E 100.9

P/B 5.6

Current Price ₹457.6

Book Value ₹ 81.7

Face Value 10

52W High ₹600

Dividend Yield 0.66%

52W Low ₹ 137

Edit Ratio

Quick Heal Tech Research see more...

Overview Inc. Year: 1995Industry: IT - Software

Quick Heal Technologies Ltd, previously Quick Heal Technologies Pvt. Ltd, is a provider of security software program merchandise and solutions in India. The Company is engaged inside the sale of Internet safety merchandise and software support offerings. Its anti-virus products are available throughout all the 4 segments: retail, small and medium enterprise (SMB), enterprise and cell. The Company gives products, consisting of Quick Heal Total Security; Quick Heal Internet Security; Quick Heal AntiVirus Pro; Quick Heal Total Security for Mac; Quick Heal Tablet Security for Android; Quick Heal Total Security for Android; Quick Heal PCTuner 3.0; Guardian NetSecure; Quick Heal Mobile Security for Android; Fonetastic Pro; Quick Heal Gadget Securance; Seqrite Endpoint Security; Seqrite Mobile Device Management (MDM), and Seqrite Server Security. Its products are offered below brands Quick Heal and Seqrite. Its solutions are designed to suit authorities institutions and company houses, among others.

Quick Heal Tech Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Quick Heal Tech Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	80	104	61	101	67	49	51	78	82	80
Other Income	4	6	3	5	3	10	5	6	4	7
Total Income	83	109	64	106	70	59	56	84	86	87
Total Expenditure	59	69	60	73	78	65	67	67	70	70
Operating Profit	24	41	4	34	-8	-6	-10	17	16	17
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	5	5	4	4	4	4	3	3	3	3
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	20	36	0	30	-12	-10	-13	13	13	14
Provision for Tax	5	8	0	7	-3	-3	-1	1	2	-0
Profit After Tax	14	28	0	22	-9	-7	-13	13	10	14
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	14	28	0	22	-9	-7	-13	13	10	14
Adjusted Earnings Per Share	2.5	4.8	0	3.8	-1.8	-1.3	-2.4	2.4	1.9	2.6

Quick Heal Tech Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	205	243	286	302	300	318	315	286	333	342	278	291
Other Income	10	10	8	10	28	30	33	32	28	19	22	22
Total Income	215	253	294	312	328	348	348	318	361	361	300	313
Total Expenditure	100	138	194	200	210	198	187	195	195	235	276	274
Operating Profit	115	114	100	112	119	150	161	123	166	126	24	40
Interest	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	4	11	20	24	31	27	24	22	19	17	16	12
Exceptional Income / Expenses	0	-17	0	0	-4	0	0	0	0	0	0	0
Profit Before Tax	110	86	80	88	84	123	137	101	146	109	8	27
Provision for Tax	34	28	26	30	31	40	45	27	39	25	2	2
Profit After Tax	77	58	54	58	53	83	92	74	107	83	6	24
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	77	58	54	58	53	83	92	74	107	83	6	24
Adjusted Earnings Per Share	0	0	0	8.3	7.6	11.8	13	11.6	16.7	14.3	1.2	4.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-19%	-1%	-3%	3%
Operating Profit CAGR	-81%	-42%	-31%	-15%
PAT CAGR	-93%	-57%	-41%	-23%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	231%	35%	17%	NA%
ROE Average	1%	10%	10%	14%
ROCE Average	2%	13%	14%	20%

Quick Heal Tech Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	285	332	331	629	662	724	790	644	751	628	420
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	1	-4	-5	-6	-6	-2	-5	-0	1	2	2
Total Current Liabilities	29	47	97	86	70	55	59	50	74	86	72
Total Liabilities	314	376	423	710	725	776	844	694	827	716	493
Fixed Assets	38	82	111	142	185	173	165	158	146	112	100
Other Non-Current Assets	40	71	92	77	45	35	46	57	49	70	70
Total Current Assets	236	223	221	491	495	568	634	479	631	535	323
Total Assets	314	376	423	710	725	776	844	694	827	716	493

Quick Heal Tech Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	3	6	5	13	117	59	12	13	10	16	8
Cash Flow from Operating Activities	68	61	77	78	36	94	61	71	99	80	31
Cash Flow from Investing Activities	-63	-59	-53	-163	-73	-122	-37	148	-92	126	185
Cash Flow from Financing Activities	-1	-2	-17	189	-20	-19	-24	-221	0	-214	-212
Net Cash Inflow / Outflow	4	-1	7	104	-57	-47	1	-3	6	-9	4
Closing Cash & Cash Equivalent	6	5	13	117	59	12	13	10	16	8	12

Quick Heal Tech Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	0	0	8.27	7.59	11.79	13.01	11.59	16.66	14.34	1.21
CEPS(Rs)	13.32	11.33	12.12	11.66	12.01	15.62	16.35	14.97	19.69	17.34	4.22
DPS(Rs)	2.5	1.55	7.5	2.5	2.5	3	2	4	4	4.5	2.5
Book NAV/Share(Rs)	0	0	0	89.72	94.17	102.63	111.6	99.94	116.56	106.98	77.29
Core EBITDA Margin(%)	51.29	42.98	32.09	33.74	30.05	37.81	40.61	31.94	41.33	31.25	0.68
EBIT Margin(%)	53.89	35.43	27.9	29.17	27.96	38.77	43.51	35.41	43.88	31.79	2.88
Pre Tax Margin(%)	53.89	35.43	27.9	29.17	27.96	38.77	43.51	35.41	43.88	31.79	2.88
PAT Margin (%)	37.51	24.04	18.81	19.17	17.74	26.08	29.16	26.01	32.12	24.33	2.3
Cash Profit Margin (%)	39.67	28.5	25.87	27.02	28.06	34.54	36.63	33.58	37.97	29.42	8.05
ROA(%)	28.29	16.93	13.47	10.23	7.42	11.06	11.33	9.68	14.07	10.79	1.06
ROE(%)	31.05	18.91	16.21	12.07	8.26	12.01	12.16	10.41	15.39	12.15	1.24
ROCE(%)	44.61	27.87	24.05	18.34	12.99	17.82	18.1	14.13	20.94	15.76	1.53
Receivable days	127.28	110.22	85.55	94.93	115.33	114.82	132.21	151.93	144.55	172.19	193.34
Inventory Days	2.57	6.39	8.97	8.77	8.89	7.78	6.38	7.42	5.25	4.34	6.1
Payable days	670.99	828.61	768.48	956.17	1165.35	1037.41	1026.39	1411.24	1392.01	1496.02	1923
PER(x)	0	0	0	26.29	31.15	22.52	17.34	7.01	11.2	12.38	110.45
Price/Book(x)	0	0	0	2.42	2.51	2.59	2.02	0.81	1.6	1.66	1.72
Dividend Yield(%)	0	0	0	1.15	1.06	1.13	0.89	4.92	2.14	2.53	1.88
EV/Net Sales(x)	-0.01	0.21	0.17	4.15	4.83	5.36	4.63	1.54	3.34	2.83	2.5
EV/Core EBITDA(x)	-0.02	0.45	0.48	11.21	12.22	11.35	9.08	3.59	6.73	7.67	28.95
Net Sales Growth(%)	14.54	18.45	17.82	5.58	-0.7	6.11	-1.06	-9.14	16.39	2.66	-18.66
EBIT Growth(%)	11.35	-22.13	-7.21	10.37	-4.81	47.15	11.02	-26.06	44.24	-25.63	-92.62
PAT Growth(%)	12.8	-24.08	-7.84	7.63	-8.08	55.95	10.62	-18.96	43.76	-22.23	-92.31
EPS Growth(%)	0	0	0	0	-8.18	55.31	10.35	-10.94	43.74	-13.92	-91.59
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0	0
Current Ratio(x)	8.25	4.71	2.28	5.7	7.11	10.37	10.69	9.56	8.53	6.2	4.5
Quick Ratio(x)	8.17	4.58	2.2	5.62	6.99	10.27	10.6	9.43	8.49	6.15	4.43
Interest Cover(x)	0	0	0	0	0	0	0	0	0	0	0
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

Quick Heal Tech Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	72.92	72.86	72.84	72.78	73.08	73.08	73.08	73.06	72.76	72.48
FII	1.57	1.77	1.74	1.76	2.17	2.04	2.02	1.56	1.66	1.65
DII	0	0	0	0	0	0	0	1.13	1.44	2.06
Public	25.51	25.37	25.42	25.46	24.75	24.88	24.9	24.25	24.14	23.81
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	4.23	4.23	4.23	4.23	3.88	3.88	3.88	3.88	3.88	3.88
FII	0.09	0.1	0.1	0.1	0.12	0.11	0.11	0.08	0.09	0.09
DII	0	0	0	0	0	0	0	0.06	0.08	0.11
Public	1.48	1.47	1.47	1.48	1.31	1.32	1.32	1.29	1.29	1.27
Others	0	0	0	0	0	0	0	0	0	0
Total	5.8	5.8	5.8	5.81	5.31	5.31	5.31	5.31	5.33	5.35

Pros

Company is almost debt free.

Cons

Company has a low return on equity of 10% over the last 3 years.
Debtor days have increased from 1496.02 to 1923days.
Stock is trading at 5.6 times its book value.
The company has delivered a poor profit growth of -40% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.